跳至主要内容
临床试验/NCT06167772
NCT06167772已完成不适用

Effects of Leucine-enriched Branched-chain Amino Acid on Muscle Thickness, Interleukin-6, and Sequential Organ Failure Assessment Score in Critically Ill Patients

Indonesia University3 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年12月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
3
主要终点
Muscle thickness

研究概览

简要总结

The goal of this clinical trial study is to test effects of leucine-enriched branched-chain amino acid (BCAA) in critically ill patients. The main questions it aims to answer are: • How are the changes in muscle thickness between groups at baseline and end of study • Is there a decrease in interleukin-6 levels between groups at baseline and end of study • Is there a decrease in sequential organ failure assessment score between groups at baseline and end of study. Participants will be given leucine-enriched branched-chain amino acid 40 g/day enterally or parenterally for 10 days. Researchers will compare with control groups to see if there is any changes between groups at baseline and end of study.

详细描述

The goal of this clinical trial study is to test effects of leucine-enriched branched-chain amino acid (BCAA) in critically ill patients. The main questions it aims to answer are: • How are the changes in muscle thickness between groups at baseline and end of study • Is there a decrease in interleukin-6 levels between groups at baseline and end of study • Is there a decrease in sequential organ failure assessment score between groups at baseline and end of study. Participants will be given leucine-enriched branched-chain amino acid 40 g/day enterally or parenterally for 10 days. Researchers will compare with control groups to see if there is any changes between groups at baseline and end of study. Both groups will be given standard nutrition with target energy of 20 kcal/kg bodyweight(BW)/day and ratio of nitrogen:non-protein calorie 1:70 and neuromuscular electrical stimulation 30 minutes per day.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • new admission to intensive care unit (ICU) in first 24 hours
  • aged 18-65 years
  • SOFA score >= 4

排除标准

  • ultrasound examination cannot be performed under these circumstances: deformities, open wounded, prosthetics on right leg, amputated above right patella
  • body mass index <16 kg/m2
  • chronic kidney disease stage 3-5
  • diabetes mellitus uncontrolled blood glucose (BG) (BG >200 mg/dL)
  • neuromuscular diseases with musculus quadriceps femoris dextra paralysis
  • autoimmune diseases
  • referral from another ICU

结局指标

主要结局

Muscle thickness

时间窗: 10 days

Quadriceps femoris dextra muscle thickness between groups at baseline and end of study

次要结局

  • Interleukin-6(10 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

dr. Yohannessa Wulandari, M.Gizi, Sp GK

Principal Investigator, Clinical nutrition specialist; PhD student

Indonesia University

研究点 (3)

Loading locations...

相似试验